RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS

Purpose: To compare the possibility of using multiple-gated acquisition scan (MUGA) and 99mTc-MIBI GATE SPECT for evaluation and forecast of anthracycline–induced cardiotoxicity in breast cancer patients. material and methods. The study included 67 women (mean age – 44 ± 4.9 years) with breast cance...

Full description

Bibliographic Details
Main Authors:	V. I. Chernov, T. L. Kravchuk, R. V. Zel’chan, V. E. Gol’dberg, N. O. Popova, E. I. Simolina, V. V. Vysockaja, Ju. V. Belevich, I. G. Sinilkin, A. А. Medvedeva, O. D. Bragina
Format:	Article
Language:	Russian
Published:	Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-12-01
Series:	Sibirskij Onkologičeskij Žurnal
Subjects:	multiple-gated acquisition scan gate single photon emission tomography 99mtc-methoxyisobutylisonitrile anthracycline-induced cardiotoxicity breast cancer
Online Access:	https://www.siboncoj.ru/jour/article/view/440

Similar Items

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Anthracycline cardiomyopathy
by: Vasiliy Nefedovich Anokhin, et al.
Published: (2011-10-01)

Radionuclide teranostic of malignancies
by: V. I. Chernov, et al.
Published: (2016-11-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies
by: Aws Sabah Al-Rubaye, et al.
Published: (2019-01-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

ANTHRACYCLINE CARDIOTOXICITY MODELING USING INTRACELLULAR ATP LEVELS IN NEONATAL RAT HEART CELL CULTURES (CHEMOTHERAPY, DOXORUBICIN, MYOCYTES)
by: Bozak, Karen Aline, 1960-
Published: (1986)

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
by: Raquel Araujo-Gutierrez, et al.
Published: (2021-01-01)

Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
by: Haupt, Luis Peter
Published: (2018)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020-05-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

State of Vegetative Homeostasis in Children with Anthracycline-Induced Cardiomyopathy
by: T.V. Shatynska, et al.
Published: (2014-03-01)

Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review
by: Simona Serini, et al.
Published: (2017-12-01)

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
by: Koichi Egashira, et al.
Published: (2021-06-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01)

Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies
by: Willeke R. Naaktgeboren, et al.
Published: (2021-09-01)

Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
by: Nhan Nguyen, et al.
Published: (2021-06-01)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
by: Timothy N. McOwan, et al.
Published: (2020-05-01)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
by: Rui Zhao, MBBS, et al.
Published: (2020-03-01)

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

Studies on heterocyclic compounds related to anthracyclines
by: Harper, Mark F.
Published: (1985)

Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)
by: Keiko Inoue, et al.
Published: (2021-03-01)